Kala Bio secures exclusive U.S. distribution deal with Virotek
Kala Bio entered an exclusive distribution and reseller agreement with Virotek for an ophthalmic genetic testing and screening program in the U.S. Exclusive rights convert to non-exclusive if a milestone due Sep 3, 2027 is not met.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.